News

Fintel reports that on April 25, 2025, Goldman Sachs upgraded their outlook for Charles Schwab Corporation - Preferred Stock ...
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Goldman Sachs (GS) have what it takes? Let's find out.
The retention packages for Chief Executive Officer David Solomon and President John Waldron give the latter more reason to ...
Within consumer staples, its preferred stocks are Godrej Consumer Products Ltd. (home insecticide growth from new ...
NEW YORK (Reuters) -Goldman Sachs shareholders voted to approve pay packages, including hefty retention bonuses, for top ...
Within a year, he joined Goldman Sachs, where he spent three years ... delivering almost $4 billion in profits for the fund during his time there. He later brought this expertise over to his ...
Nik Storonsky, the billionaire cofounder and CEO of Revolut, said his London-based fintech had a “landmark year” in 2024 as ...
Reliance Industries is seen reporting flat operating profit sequentially in the March quarter due to weak earnings in its ...
The brokerage trimmed its price target to Rs 4,210 on the company, indicating a 7.2% downside, while maintaining its 'neutral' call.
Its net profit in 2023 was $6.3m. During 2024, Goldman Sachs shot to top spot for mergers and acquisition advisory roles on the LSEG investment banking league table, advising on 32 deals worth ...
For foreign companies, it means “you’ll either have to raise prices, or lower profits,” he said, dryly. “It is always this ...
Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK825.00.